Syros Pharmaceuticals, Inc. - Neraca (Quarterly)

Syros Pharmaceuticals, Inc.
US ˙ OTCPK ˙ US87184Q2066

Talaan ng Balanse (Quarterly)

Neraca Syros Pharmaceuticals, Inc. menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
Cash 93 174 222 161 115 92 70 59 172 167 105 115 112 140 84 79 58
Change (%) 86.81 27.68 -27.56 -28.27 -20.03 -24.62 -15.11 190.42 -2.37 -37.44 10.19 -2.79 24.33 -40.14 -5.46 -26.20
Assets Current 99 179 227 186 153 137 116 92 252 211 174 153 123 145 112 85 64
Change (%) 81.16 26.95 -17.85 -17.69 -10.89 -14.72 -21.06 174.41 -16.22 -17.86 -12.10 -19.73 18.34 -22.61 -24.31 -24.72
Assets 133 213 261 234 208 183 152 126 285 244 205 181 148 168 135 107 85
Change (%) 59.94 22.22 -10.32 -10.99 -12.07 -16.87 -17.00 125.55 -14.13 -16.02 -11.85 -18.34 13.79 -19.89 -20.79 -20.36
Liabilities 87 123 111 104 102 98 89 95 156 117 99 108 111 152 120 113 96
Change (%) 40.39 -9.74 -6.31 -1.71 -4.18 -8.57 6.58 63.37 -24.95 -15.57 9.31 3.48 35.89 -21.02 -5.51 -15.00
Equity 46 91 150 130 106 85 63 31 129 128 107 73 36 17 15 -6 -11
Change (%) 97.11 65.52 -13.28 -18.40 -19.65 -26.37 -50.56 316.43 -1.11 -16.43 -31.39 -50.43 -54.10 -9.63 -142.19 75.11
Liabilities And Stock Equity 133 213 261 234 208 183 152 126 285 244 205 181 148 168 135 107 85
Change (%) 59.94 22.22 -10.32 -10.99 -12.07 -16.87 -17.00 125.55 -14.13 -16.02 -11.85 -18.34 13.79 -19.89 -20.79 -20.36

Source: Capital IQ

Other Listings
GB:0LC7
DE:0S90
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista